Fig. 6
From: Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
Reprinted with permission [90]. Copyright 2022, Wiley-VCH GmbH.
 A Schematic illustration of the formation of Polymer@Gef-siRNA NPs. B Representative in vivo images of PDX-bearing mice. C Tumor volume changes of mice treated with saline (G1), free Gefitinib (G2), Polymer@Gef-YAP-siRNA (G3), and Polymer@Gef-YAP-siRNA + Laser (G4), respectively. D Western blotting images of tumor tissues.